Acro Biomedical (ACBM) Operating Leases (2019 - 2025)

Acro Biomedical's Operating Leases history runs 7 years deep, the most recent figure standing at $13651.0 for Q2 2025.

• In Q2 2025, Operating Leases fell 65.66% year-over-year to $13651.0; the TTM figure through Jun 2025 stood at $13651.0 (down 65.66% YoY), while the FY2024 annual figure was $26898.0, down 48.5% from the prior year.
• Operating Leases was $13651.0 for Q2 2025 at Acro Biomedical, down from $18009.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $52233.0 in Q4 2023 to a low of $5888.0 in Q3 2021.
• Historically, Operating Leases has averaged $27107.9 across 5 years, with a median of $25719.0 in 2021.
• The sharpest annual moves came in 2021 and 2022: Operating Leases slumped 66.79% in 2021, then jumped 443.31% in 2022.
• A 5-year view of Operating Leases shows it stood at $25719.0 in 2021, then changed by 0.0% to $25719.0 in 2022, then surged by 103.09% to $52233.0 in 2023, then tumbled by 48.5% to $26898.0 in 2024, then sank by 49.25% to $13651.0 in 2025.
• The last three Operating Leases figures came in at $13651.0 (Q2 2025), $18009.0 (Q1 2025), and $26898.0 (Q4 2024), per Business Quant data.